Seoul, South Korea

Dong Yoon Park

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Digital Genomics Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Yoon Park. Retrieved from https://idiyas.com/inventor/dong-yoon-park-ivrictb5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dong Yoon Park

Introduction

Dong Yoon Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer detection. His work is characterized by a commitment to advancing healthcare through innovative solutions.

Latest Patents

Dong Yoon Park holds a patent for "Markers for the diagnosis of lung cancer." This invention discloses a diagnostic marker that is specific for lung cancer. The patent also relates to a composition and a kit that includes an agent for measuring the presence of the marker. Furthermore, it outlines a method for diagnosing lung cancer using the composition or kit.

Career Highlights

Dong Yoon Park is currently associated with Digital Genomics Inc., where he continues to work on groundbreaking research and development in genomics and diagnostics. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Some of his notable coworkers include Jeong Ho Yoon and Se Nyun Kim. Their collaborative efforts contribute to the innovative environment at Digital Genomics Inc.

Conclusion

Dong Yoon Park's contributions to lung cancer diagnostics exemplify the impact of innovation in healthcare. His work not only advances medical technology but also holds the potential to save lives through early detection and diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…